Skip to content

Clinical trials

Phase 2 Hypoglycemia trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoglycemia Phase: Phase 2 Country / region: Canada Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20081
20123
20134
20144
20152
20163
20182
20192
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Withdrawn4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institut de Recherches Cliniques de Montreal16
Jaeb Center for Health Research2
Anelixis Therapeutics, LLC1
Eli Lilly and Company1
National Institute of Allergy and Infectious Diseases (NIAID)1
Rezolute1
University of British Columbia1
Xeris Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoglycemia24
Diabetes Mellitus, Type 119
Insulin Resistance16
Diabetes Mellitus, Type 22
Metabolic Diseases2
Autoimmune Diseases1
Congenital Hyperinsulinism1
Diabetes Mellitus1
Digestive System Diseases1
Endocrine System Diseases1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.